[TNGX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TNGX] Tango Therapeutics, Inc.
Announcement Date
18-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -38.18%
YoY- -5.86%
Quarter Report
TNGX's Result
TNGX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 11,607 19,875 6,471 5,431 10,732 14,598 5,766 59.22%
PBT -29,113 -25,486 -37,874 -30,716 -22,240 -20,646 -28,008 2.60%
Tax -54 65 40 47 23 64 -2,278 -91.69%
NP -29,167 -25,551 -37,914 -30,763 -22,263 -20,710 -25,730 8.69%
Tax Rate - - - - - - - -
Total Cost 40,774 45,426 44,385 36,194 32,995 35,308 31,496 18.72%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin -251.29 -128.56 -585.91 -566.43 -207.45 -141.87 -446.24 -31.73%
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.27 -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -4.63%
EPS Diluted -0.27 -0.24 -0.35 -0.32 -0.23 -0.23 -0.29 -4.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.